Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Sep 10, 2024
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Tax Payment
Common Stock
[F1]2024-09-08$60.51/sh−3,646$220,619→ 373,859 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,127 shares of restricted stock, the grant of which was previously reported.
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook|2024-09-10